Abstract | Sodium transport in the distal nephron is mediated by epithelial sodium channel activity. Proteolytic processing of external domains and inhibition with increased sodium concentrations are important regulatory features of epithelial sodium channel complexes expressed in the distal nephron. By contrast, sodium channels expressed in the vascular system are activated by increased external sodium concentrations, which results in changes in the mechanical properties and function of endothelial cells. Mechanosensitivity and shear stress affect both epithelial and vascular sodium channel activity. Guyton's hypothesis stated that blood pressure control is critically dependent on vascular tone and fluid handling by the kidney. The synergistic effects, and complementary regulation, of the epithelial and vascular systems are consistent with the Guytonian model of volume and blood pressure regulation, and probably reflect sequential evolution of the two systems. The integration of vascular tone, renal perfusion and regulation of renal sodium reabsorption is the central underpinning of the Guytonian model. In this Review, we focus on the expression and regulation of sodium channels, and we outline the emerging evidence that describes the central role of amiloride-sensitive sodium channels in the efferent (vascular) and afferent (epithelial) arms of this homeostatic system.
Introduction
The regulated reabsorption of filtered sodium (Na + ) by the nephron has an important role in the control of extracellular fluid volume and blood pressure. 1 Na + transport in the distal nephron is mediated by epithelial Na + channels (ENaCs), which are expressed in the apical cellular membranes.
2-4 The role of these channels in the control of blood pressure is highlighted by gain-of-function mutations that are associated with an increase in blood pressure and Liddle syndrome, and loss-of-function mutations that are associated with a decrease in blood pressure and pseudohypoaldosteronism type I.
5-10
ENaCs also facilitate Na + transport across airway and alveolar epithelia, where they are involved in modulating the volume of fluids in the airways and alveoli. [11] [12] [13] These channels are found in other epithelia and other cell types, including vascular endothelial cells and vascular smooth muscle. 14, 15 ENaCs are members of the ENaC/Degenerin family of cation-selective ion channels. 16, 17 They are composed of three subunits, termed α, β and γ, which share similar structural features-with two transmembrane domains separated by a large extracellular region, and short cytoplasmic amino-terminal and carboxyl-terminal tails (Figure 1) . 4, [17] [18] [19] [20] This Review focuses on ENaCs expressed in the kidney, and amiloride-sensitive Na + channels expressed in vascular endothelial and smooth muscle cells. Our primary aim is to place the regulation of vascular tone into context with the regulation of vascular Na + channel activity, with a focus on the similarities and differences between ENaCs and vascular amiloride-sensitive Na + channel activity. We consider the complementary roles both systems have in the regulation of volume homeostasis and blood pressure.
ENaCs in the distal nephron
The cells of the distal part of the distal convoluted tubule, connecting tubule and collecting duct are the main sites involved in hormonal regulation of ENaC activity. Aldosterone maintains the balance of Na + and potassium (K + ) by controlling Na + reabsorption and K + secretion in the distal nephron. Glucocorticoid receptors are ubiquitously expressed in the glomerulus and the entire nephron, whereas mineralocorticoid receptors are expressed in specific segments of the distal nephron. The results from studies using highly specific anti bodies demonstrate that mineralocorticoid receptors are coexpressed with glucocorticoid receptors in the distal nephron.
mineralocorticoid receptors compared to later, or more tonic, effects of aldosterone (that could even be mediated via glucocorticoid receptors). The aldosterone-sensitive distal nephron (ASDN) has been defined as the distal part of the distal convoluted tubule, connecting tubule and collecting tubule based on the criterion of coexpression of mineralocorticoid receptors and 11-β-HSD2.
1,25
Na + and K + balance, and the regulation of blood pressure, are achieved through the final regulation of transport in the distal nephron and the collecting duct under hormonal control (including aldosterone, vasopressin, angiotensin, insulin, bradykinin and endothelin). 1 The mechanisms by which these hormones regulate renal ENaCs have been the focus of numerous reviews. 3, 4, 9, [26] [27] [28] [29] Aldosterone increases expression of the α subunit as well as many other proteins, including serum/glucocorticoidregulated kinase 1 (SGK1), and the adaptor proteins glucocorticoid-induced leucine zipper protein (GILZ) and connector enhancer of kinase suppressor of Ras 3 (CNK3), all of which enhance surface expression of ENaC channels.
3,30-35
The renin-angiotensin system is well described as the primary regulator of aldosterone secretion in response to extra-cellular volume challenges. All of the components of this system along the nephron, 36, 37 and the regulation of ENaC activity in the ASDN via apically located angiotensin II type 1 receptors, have now been described. 38 Another potentially important feature is mutual interactions between the apically expressed AT1 receptor and the cytoplasmic mineralocorticoid receptor, mediated by kinase phosphorylation cascades. [39] [40] [41] [42] The responsiveness of luminal renin activity in the connecting tubule to changes in dietary Na + intake is a notable aspect of the intrarenal renin-angiotensin system. 36 Internalization and degradation of ENaC Ubiquitination of ENaCs at the plasma membrane targets channels for internalization and degradation. 43, 44 Protein interacting modules within the WW domains of the E3 ubiquitin protein ligase NEDD4-2 and the PY motifs in the carboxyl termini of ENaC subunits facilitate interactions between these two protein complexes.
44-46 Both SGK1 and GILZ reduce the extent of
Key points
■ Renal perfusion pressure, glomerular filtration and net renal sodium reabsorption maintain volume homeostasis ■ Cell stiffness and myogenic tone contribute to peripheral vascular resistance in the presence of aldosterone and normal sodium concentrations in the arterial circulation ■ Structural similarities exist between the amiloride-sensitive sodium channels in the epithelial and endothelial cells ■ Distinctions based on functional differences, especially in response to changes in extracellular sodium concentrations, might permit development of novel pharmacological approaches to differentially target epithelial and endothelial sodium channels ■ Agents that preferentially inhibit the vascular channels could lower systemic blood pressure without the associated inhibition of potassium secretion that accompanies the available sodium channel blockers and mineralocorticoid receptor antagonists channel internalization and ubiquitination, thus enhancing ENaC channel surface expression. 3,44 Phosphorylation of NEDD4-2 by SGK1 or vasopressin and the subsequent recruitment of 14-3-3 adaptor proteins to phosphorylated NEDD4-2 hinders interactions between NEDD4-2 and ENaC subunits, thus prolonging the dwell time of ENaCs in the apical membrane.
47-51 Mitogen activated protein (MAP) kinase signalling via (extra cellular signalregulated kinase) ERK-1/ERK-2 enhances interactions between NEDD4-2 and ENaC subunits-thought to be due to ERK1/2-dependent phosphorylation of the carboxyl terminus of the β and γ subunits of ENaC. 3, 52, 53 GILZ inhibits RAF proto-oncogene serine/threonineprotein kinase (cRaf) early in the MAP kinase signalling pathway and subsequent ERK1/2-dependent phosphorylation of ENaC subunits, 54 and also recruits SGK1 to a complex with ENaC and other regulatory components. 3 The results from cell-based studies also indicate that internalized ENaCs are modified by a number of deubiquitin ating enzymes, which enhance recycling of the internalized channel to the plasma membrane.
55-62
Other cytoplasmic factors have important roles in reg ulating channel activity. The interaction of specific inositol phospholipids ( phosphatidylinositol 4,5-bisphosphate [PIP 2 ] and phosphatidylinositol 3,4,5-triphosphate [PIP 3 ]) with basic cytoplasmic residues enhances channel activity. Regulatory cascades that alter expression of these inositol phospholipids also, therefore, affect channel activity. [63] [64] [65] [66] For example, purinergic P2Y receptor activation inhibits ENaCs in association with the activation of phospho lipase C and reduction in membrane PIP 2 .
67-69 Modification of channel subunits by palmitoylation (the attachment of fatty acids) activates the channel, possibly by conformational changes induced by the interaction of palmitate with the plasma membrane. 
Proteolytic processing of ENaC
The extracellular regions of acid sensing ion channels (ASICs) and ENaCs share similar structural features. 17, 72, 73 The crystal structure of ASIC1 74-77 has revealed that these large extracellular regions are highly organized structures. ENaC activity is regulated by extracellular factors that modulate channel gating through interactions at sites within the extracellular region of ENaC subunits.
78,79 Channels that have not undergone proteolytic processing, for example, have very low activity at the cell surface.
80,81 Specific proteases activate ENaCs by cleaving the α or γ subunits at defined sites in the extracellular domains. 17, 73, 78, 80, 82 Furin is a serine protease that resides primarily in the trans-Golgi network and processes proteins moving through the biosynthetic pathway. 83 The α subunit of ENaC is cleaved twice by furin leading to moderate channel activation. 84 The γ subunit is cleaved only once by furin, and must be cleaved by a second protease to further activate the channel. 82 A number of proteases, including prostasin, transmembrane protease serine 4, matriptase-2, elastase, kallikrein-1, chymotrypsin and plasmin activate the channel by cleaving the γ subunit. 78, 82, [85] [86] [87] [88] [89] [90] The α subunit Trp493Arg variant, 91 the γ subunit Leu511Gln variant, 4 and the β subunit Val348Met variant 92 show less activation by chymotrypsin, and increased baseline channel activity. Cysteine, alkaline and metalloproteases also activate ENaCs. 88, [93] [94] [95] At present, the key proteases that cleave and activate the channel in different physiological states have not been defined. Proteases often work in functional cascades, and it will be important to determine which functional protease cascades are involved in channel activation. Prostasin and kallikrein-1 might be involved in activating the channel in the setting of volume depletion, or in response to aldosterone. 96 Plasminogen is filtered by damaged glomeruli and is cleaved by tubular urokinase to plasmin, which directly cleaves and activates ENaCs. 87, 97, 98 In addition, plasmin can activate ENaCs by cleaving and activating prostasin. 99 Protease activation of ENaCs provides a potential explanation for the renal Na + retention that occurs in some individuals with nephrotic syndrome despite suppression of the reninangiotensin system owing to the activation of distal Na + transport mechanisms.
97,100
Na + self-inhibition of ENaC Inhibition of ENaC activity by an increase in extracellular Na + , referred to as 'Na + self-inhibition' , reflects low affinity interactions between Na + and sites in the extracellular region of ENaC.
17,101-103 ENaC activity is also inhibited by an increase in intracellular Na + concentrations, which results in a reduction in the probability of the channel being open and a reduction in surface expression, referred to as 'feedback inhibition' or 'channel run-down'. [104] [105] [106] These mechanisms are involved in modulating channel activity in the distal nephron, where reductions in the urinary Na + concentration (to low millimolar ranges) facilitate channel activation. Increases in extracellular Na + , with increased ENaCs are exposed to varying rates of tubular flow and laminar shear stress. Isolated perfused tubules respond to increases in the rate of tubular perfusion with an increase in amiloride-sensitive Na + absorption mediated by ENaCs. 109 Channel activation by shear stress has also been shown in heterologous systems, such as Xenopus laevis oocytes, and at a single channel level with an outsideout patch configuration. 102, 110 Shear stress seems to be sensed by the large extracellular region of ENaCs, where it induces a conformational change that is transmitted to the channel gate leading to an increase in channel activity. 108, [111] [112] [113] Shear stress directly activates ENaCs, whereas increases in distal flow lead to a release of cellular ATP that likely dampens flow-dependent channel activation through stimulation of P2Y2 (P2Y purinoceptor 2) receptors.
69, 114 The flow-induced increase in ENaC activity might facilitate K + secretion, which is also activated by increases in tubular flow rates. 115 Salt-sensitive hypertension Mutations in the β or γ subunit genes (SCNN1B and SCNN1G) that either truncate the cytoplasmic carboxyl terminus (with a loss of the PY motif), or result in a missense mutation of a vital residue in the PY motif, have been described in individuals with Liddle syndrome. 5, 6, 8 A loss of the PY motif, as discussed above, disrupts the binding of NEDD4-2 to the channel, thus leading to a reduction of channel ubiquitination and an increase in channel surface expression and activity. 43, 44 These mutations result in robust channel activation and early onset hypertension that is notably impacted by dietary salt intake. 8, 116, 117 An important question is whether there are other ENaC gene variants that activate the channel and increase the risk of salt-sensitive hypertension. Currently there are almost 4,000 reported variants in human ENaC genes, including single nucleotide polymorphisms (SNPs), insertions and deletions. Some SNPs change an amino acid, and several of these have been shown to alter ENaC activity when expressed in heterologous systems. 4, 92, [118] [119] [120] [121] Several variants in the extracellular region, including the α subunit Trp493Arg, γ subunit Leu511Gln and β subunit Val348Met variants, lead to large increases in channel activity.
4,91, 92 The results from functional studies have shown the enhanced activity associated with the γ subunit Leu511Gln and α subunit Trp493Arg variants is due, in part, to a loss of Na + selfinhibition. 4, 91 Other sites also exist, where mutations will likely increase channel activity, including sites in the transmembrane domain that are in the vicinity of the channel gate. Whether specific channel activating variants, in addition to those described in patients with Liddle syndrome, increase the risk of salt-sensitive hypertension, and whether hypertension in individuals with such variants would respond to an ENaC inhibitor (such as amiloride), are important questions that have not yet been addressed. In addition to ENaC variants that affect channel activity, selected variants in genes whose products regulate ENaC activity are likely to increase the risk of salt-sensitive hypertension. 1, 122, 123 A SNP has been described, for example, in the first exon of NEDD4 that corresponds to a cryptic splice site and forms a frame-shifted transcript. 124 This SNP has been associated with hypertension in Japanese males, 125 and Swedish males and females. 126 This variant leads to two isoforms of NEDD4 (with or without the C2 domain) that affect subcellular targeting and interactions between ENaC and NEDD4. 127 
Na + channels in the vasculature
The mineralocorticoid hormone aldosterone also targets the vascular endothelium and smooth muscle cells, and regulates vasoreactivity through several processes involving ion channel modulation. In the endothelium, it swells, 128 stiffens 129, 130 and renders endothelial cells sensitive to increases in extracellular Na + concentration.
15, 131 These endothelial effects of aldosterone action are mediated by amiloride-sensitive Na + channels. 129 Several research groups have shown that vascular endothelial cells have amiloride-sensitive Na + channel activity. 130, 132, 133 Sufficient molecular evidence to conclude that these channels are different from ENaCs is not yet available, but, because of the striking differences in response to changes in external Na + concentrations, we will refer to the endothelial cell amiloride-sensitive Na + channel activity as 'EnNaCs' . Furthermore, endothelial cells express mineralocorticoid receptors, [134] [135] [136] as well as 11-β-HSD2, which confer mineralocorticoid specificity, 137 although the relative activity of 11-β-HSD2 at the local tissue level in vascular cells is an important issue that needs to be clarified further. 138 Endothelial expression and membrane insertion of EnNaCs is enhanced by aldosterone. [139] [140] [141] Amiloride is associated with inactivation of EnNaC activity at the cell surface. 140 Thus, vascular endothelial cells possess all the components for aldosterone-mediated Na + transport across the plasma membrane.
In contrast to the 'tight' epithelia in the ASDN, 1,3,4,142,143 the vascular endothelium is a 'leaky' barrier, with well described fenestrae. 144 Therefore, passive electrochemical gradients and Starling forces (capillary hydrostatic and osmotic pressures) drive most of the net Na + transport across the vascular wall via paracellular pathways (passing between the epithelial cells). EnNaCs might not have any role in net Na + transport across the vascular wall, although they are involved in controlling the mechanical properties (stiffness) of endothelial cells (Figure 2 ). The endothelial glycocalyx is a surface layer, which is a negatively charged biopolymer known to function as an effective Na + buffering system. 14 Acute increases in ambient Na + concentrations derange the glyco calyx in parallel to the increased EnNaC abundance in the plasma membrane and increased Na + entry. 15 Additionally, this layer could dampen shear-stress modulation of EnNaC activity, providing another mechanism by which acutely increased ambient Na + concentrations and deranged glycocalyx could modulate plasma membrane EnNaC activity.
Shortly after ingestion of a meal with 6 g of added salt, normal volunteers have acute increases in blood pressure that correlate with acute increases in plasma Na + concentration-a 1 mM increase is associated with a 1.9 mmHg increase in systolic blood pressure. Figure 2 | Model of EnNaC-dependent transition from endothelial function to dysfunction. a | Normally, the endothelial cell is protected by a well-developed glycocalyx and membrane expression of EnNaC is low. Thus, the access of Na + into the endothelial cell is limited, NO is released and vasodilation is maintained. b | Increased EnNaC membrane abundance, together with deranged glycocalyx, 14,15 facilitate Na + entry into endothelial cells and triggers the polymerization of G-actin to F-actin. NO release is, as a result, reduced and the plasma membrane and immediate sub-membrane compartment 'stiffens'. Abbreviations: EnNaC, endothelial cell amiloride-sensitive Na + channel; NO, nitric oxide.
Plasma Na + concentrations are chronically increased by approximately 1-3 mM in hypertensive individuals and patients with primary aldosteronism. 145, 147 Patients with moderately severe chronic kidney disease might have volume expansion, as evidenced by left atrial enlargement in association with serum Na + concentrations >140 mM. 148 Using an atomic force microscope as a nano sensor, the mechanical properties of endothelial cells have been probed in the presence of aldosterone and acute changes in extracellular Na + concentrations within the physio logical range. 131 Within minutes, acute elevation of Na + concentrations from 135-145 mM rapidly increase endothelial cell stiffness, and this response is blocked by amiloride. Observations of Na + -mediated regulation of surface expression of EnNaCs now show that exposure to 150 mM Na + doubles the expression of EnNaCs at the endothelial cell surface. These changes in ambient Na + concentration, although far greater than the usual variations in serum Na + concentration, have been interpreted as showing that endothelial EnNaC activity is controlled by a 'feed-forward mechanism' , presumably by some sort of extracellular Na + sensor. 149 This phenomenon is opposite to ENaC activity in the ASDN, where increased Na + concentrations reduce ENaC activity through self-inhibition and feed-back regulation. [104] [105] [106] 150 It should be noted that the electrophysiological properties of EnNaCs have not been charac terized and, therefore, defining the cation selectivity and amiloride sensitivity of EnNaCs in the activated state will be important.
The underlying mechanism of Na + -induced EnNaC membrane insertion has not been defined. The combination of aldosterone and acute increases in ambient Na + concentrations from 135-145 mM seem to trigger the rapid membrane insertion of preformed EnNaC complexes residing in the membrane of vesicles underneath the plasma membrane. 141 By analogy to the regulation of ENaC surface expression and activity, 3, 26, [30] [31] [32] [33] increased expression of EnNaC α subunits, as well as other proteins (including SGK1 and GILZ), that inhibit NEDD4-2 activity, would enhance surface expression of EnNaC complexes. This is an important area for further work; at present, only one report has been published that describes NEDD4-2 in endothelial cells. 151 Shear stress and mechanosensitivity Accumulating evidence indicates that endothelial ENaCs are involved in the control of cellular mechanics and peripheral vascular resistance. 131, 152, 153 Studying the mechanical properties of endothelial cells in vitro, and ex vivo with atomic force microscopy, has revealed a positive correlation between expression of EnNaCs and mechanical stiffness of the 50-200 nm cytoplasmic zone directly beneath the apical plasma membrane of endothelial cells ('cellular cortex'). 154 Mechanical stiffness, the resistance of a structure against deformation, reflects the physiological state of a vascular endothelium. Stiffness, in quantitative terms, both controls and reflects cellular responses to biochemical and biophysical signals. Of note, the activity of the endothelial nitric oxide synthase 3 enzyme is tightly coupled to shear stress exerted by the pulsatile blood flow. 155 Nitrous oxide (NO) release is dramatically decreased 152 when endothelial cells stiffen; 131 decreased NO release is a hallmark of endothelial dysfunction. 156 
Na
+ entry via EnNaCs influences endothelial NO synthase activity and NO production, possibly via the PI3K/ AKT signalling pathway. 157, 158 The effect of reactive oxygen species on NO activity has not been explored when EnNaC activity is stimulated by increased extracellular Na + . Long-term treatment with mineralocorticoid receptor antagonists ameliorates the endothelial dysfunction 159 that is associated with EnNaC activation. 160 Whether endothelial stiffness, as described above, is directly linked to peripheral arterial stiffness is currently unknown. However, the vascular endothelium has a crucial role in vascular tone and, consequently, in arterial stiffness. Endothelium-dependent relaxation or dilation in response to mechanical forces, such as shear stress caused by blood flow, is caused by the release of EDRF (endothelial-derived relaxing factor) or EDHF (endothelial-derived hyperpolarizing factor). In this context, local inhibition of EDRF and EDHF pathways in humans prevents the decrease in smooth muscle tone and wall stiffness of the radial artery. 161 Interactions between ENaC with F-actin, and other cytoskeletal proteins, such as spectrin or cortactin, have been well described.
45,162-164 Endothelial stiffening mediated by increased EnNaC activity seems to be related to the interaction of the C-terminus of the α subunit with F-actin in the submembraneous cortical cytoskeleton of endothelial cells. 163 The inter action of EnNaC with F-actin, and other proteins of the corti cal cytoskeleton, has been postulated to lead to the development of a submembraneous web, which determines the mechanical stiffness of this subcellular compartment (that lies immedi ately below the surface of the plasma membrane). In this context, F-actin (forming a gel-like cell cortex) stiffens, while G-actin (forming a sol-like cortex) softens the cortex. 165 An increase in EnNaC activity in the endothelial plasma membrane enhances the Na + influx into the cell, and might stabilize F-actin through strengthening of the inter-subunit contacts of the protein. 166 Therefore, the activity of ENaCs in the endothelial membrane, rather than their presence, influences cell mechanics and determines endothelial stiffness (Figure 2 ).
Vascular smooth muscle cells
ENaC subunits have also been described in vascular smooth muscle cells, which indicates that amiloridesensitive Na + channels might be involved in mechanosensing and control of peripheral vascular resistance. 167 These channels are not the prototypical ENaCs observed in epithelia. Vascular smooth muscle cells express β and γ subunits of ENaC, whereas α ENaC subunit expression is disputed. α Subunit expression has been shown (using Western-blotting and immunocytochemistry) in rat mesenteric arteries, 157 but not in rat renal and cerebral arterial segments. 165 A more complete characterization of the subunits of the amiloride-sensitive Na + channel complexes is a matter of high priority. For example, mechanoactivated whole-cell Na + currents have been described in vascular smooth muscle cells. 168 These currents were reduced when β subunit expression was reduced, but whether these mechanoactivated whole-cell currents are amiloride-sensitive is currently not known. Vascular smooth muscle cells also express ASIC subunits, and the mechanosensory channel complexes have been hypothesized to be composed of a combination of ENaC and ASIC subunits.
14, 169 Mineralocorticoid receptors are also expressed in smooth muscle cells and have been proposed to have an important role in regulating myogenic tone.
14,170,171 Whether amiloride-sensitive Na + channels are regulated by aldosterone in vascular smooth muscle cells has not been defined.
Physiological role in vivo
Pharmacological approaches have been used to assess the role of amiloride-sensitive Na + channels in vascular reactivity. Contractility studies of ex vivo rat mesenteric arteries show that acute treatment with amiloride (or benzamil) decreases the vasoconstrictive response to phenylephrine and 5-hydroxytryptamine, which suggests that amiloride-sensitive Na + channels are involved in the vasoconstrictor response. 157 However, chronic amiloride administration affects the concentration response curve to phenylephrine in the renal interlobar arteries of hypertensive rats overexpressing murine renin. 172 Pressure-induced constriction is an important response in certain blood vessels (referred to as 'myogenic tone' or 'autoregulation') that is mediated by vascular smooth muscle cells in small arteries and arterioles in the cerebral, mesenteric, cardiac, and renal circulation. Benzamil or amiloride abolishes the myogenic constriction in renal interlobar arteries in a concentration-dependent manner. 173 Additional insights into the contribution of EnNaCs to vascular tone have been obtained in genetically modified mouse models. Increased EnNaC surface expression and endothelial stiffness have been observed in the aorta of mice expressing truncated β ENaC subunits (similar to the Liddle mutation). 141, 154 These observations recapitulate the ex vivo experiments in cultured endothelial cells described above. Mice expressing low levels of β ENaC in the lung, kidney, and vascular smooth muscle cells, 174 experience a 50% reduction in pressure-induced vasoconstriction in middle cerebral arteries. 175 The use of mouse models with conditional, cell-specific inactivation or activation of the different amiloride-sensitive Na + channel subunits in the vasculature would help to dissect the cell-specific role of EnNaC subunits (Box 1).
Consequences of altered EnNaC function
Impaired autoregulation of renal haemodynamics, marked by impaired natriuresis in response to increases in systemic blood pressure, has been associated with chronic angiotensin II infusion 176 and increased activity of the renin-angiotensin system. 177, 178 Endothelin A receptor activation is proinflammatory and prohypertensive. 179 Medullary endothelin B receptor activation is associated with increased renal Na + excretion, an effect that is blunted by angiotensin II. 180 Impaired salt excretion would, therefore, occur in the setting of over-activity of the renin-angiotensin-aldosterone system, and an imbalance between endothelin A and endothelin B receptor activation. Salt-sensitive hypertension is associated with impaired sodium excretion and inflammatory infiltrates in the tubulo-interstitium. 181 Indeed, ubiquitous ENaC β subunit down-expression is associated with defective myogenic autoregulation of renal blood flow. 182 This loss of autoregulation is also associated with increased inflammatory markers and increased systemic blood pressure in a mouse model with reduced ENaC β subunit activity, 183 suggestive of a link between vascular amiloride-sensitive Na + activity and inflammation in several pathophysiological dis orders. Loss of baroreflex sensitivity in an ENaC β subunit-deficient mouse model has also been proposed to increase blood pressure variability and pressure swings. The loss of the myogenic constrictor response (owing to loss of vascular smooth muscle ENaC β activity) blunts autoregulation, and permits arterial pressure fluctuations to be transmitted to the microvascu lature, thus increasing the susceptibility to renal injury and hypertension. 184 
Box 1 | Research agenda-the next steps
Studies focusing on EnNaCs and ENaCs ■ Cloning, sequence and expression studies in light of SNPs that have been shown to affect ENaC activity. ■ Are there alternative splice sites that affect subunit structure and activity? ■ Detailed electrophysiological characterization of the EnNaC is needed before and after aldosterone-dependent Na + activation. ■ A molecular basis for Na + self-inhibition of the ENaC, and Na + activation of the EnNaC needs to be defined. ■ The link between increased Na + entry, reduced production of NO and myogenic tone needs to be defined. The role of reactive oxygen species and free radicals also need to be considered. ■ Detailed comparisons of dose-response curves for mineralocorticoid receptor blockers in the vascular and epithelial systems might yield important insights. Regulation pathways need to be explored.
Mouse models of disease ■ Mouse models with conditional cell-specific inactivation of the different Na + channel subunits. ■ The expression of different subunits (α, β, and γ) and their localization in vascular cells in mouse models of disease. ■ Tissue-specific conditional expression models and cross-transplantation models could be used to tease apart the vascular from the renal phenotypes. ■ Mouse models with conditional, cell-specific inactivation or inactivation of the mineralocorticoid receptors in endothelial and smooth muscle cells. 
Na + channels and hypertension
Pharmacological efforts are now focusing on the development of amiloride analogues, 185 non-steroidal mineralocorticoid-receptor antagonists, 186 and low-dose studies of mineralocorticoid-receptor blockers that might preferentially inhibit extra-renal ENaC and mineralocorticoid receptors. 187, 188 The hope of providing the welldescribed beneficial effects of mineralocorticoid-receptor antagonists [189] [190] [191] to patients with chronic kidney disease, without the adverse effects associated with ENaC inhibition, is well worth pursuing. Clinical studies show that aldosterone, high salt intake, or both, could be responsible, to a large extent, for the development of arter ial hypertension and harmful effects on the cardiovascular system, even independent of any significant rise in blood pressure. 145, [192] [193] [194] Competitive inhibition of aldosterone receptors by spironolactone or eplerenone, 189, 190 blockade of ENaC-mediated Na + entry by amiloride, and data now derived from animal models, 154, 195 support the view that endothelial EnNaCs contribute to the development of cardiovascular disease. ENaCs are also known to be involved in the pathogenesis of Liddle syndrome. 5, 8 In this disease, mutations in the ENaC β or γ subunits lead to a gain-of-function via an increase in surface density and activity of the channel. 6 New data show that abnormal vascular function (as well as altered kidney function) could contribute to hypertension in a mouse model of Liddle syndrome. 154 The sensitivity of endothelial stiffness to modest changes in extracellular Na + concentration, especially in the presence of aldosterone, and the subsequent dampening of NO-mediated vasodilation (Figure 3) indicates that the vascular amiloride-sensitive Na + channels might also participate in the pathogenesis of salt-sensitive hypertension in humans. 196 
Evolution of volume homeostasis
The emergence of Na-K-ATPase, together with the ENaC/Degenerin family, seems to be linked to the develop ment of multicellularity in the Metazoan kingdom. The establishment of multicellularity and the associated extracellular compartment ('internal milieu') precedes the emergence of other important elements of the aldosterone-signalling pathway. 197 In the primordial high-salt environment, it seems probable that the constant extracellular Na + concentration maintained vascular tone through tonic activation of the EnNaCs. In that environment, variations in external Na + concentrations were not an issue and, as a consequence, tonic EnNaC activation supported maintenance of vascular tone rather than responding to variations in external Na + . Once the transition to estuarine environments and dry land began, two important forces shaped the evolutionary development of the EnNaC and ENaC systems; the need to conserve Na + and to develop other pressor systems to maintain systemic perfusion (for example, angiotensin II), and salt-conserving hormones (for example, aldosterone) for when there was less salt in the environment. The EnNaC system seems to be a positivefeedback loop, and subsequent development of selfinhibition and feedback-inhibition for ENaCs expressed in the ASDN closed the feedback loop in the Guytonian sense. 9 The term 'pressure-natriuresis' describes the activity of EnNaCs and ENaCs in maintaining systemic blood pressure and volume homeostasis, 198 and refers to increased renal perfusion pressure associated with decreased Na + reabsorption and increased Na + excretion. Some of the intrarenal mechanisms for decreased Na + reabsorption seem to be related to increases in medullary blood flow and interstitial hydrostatic pressure, as a result of NO-induced reductions in renal medullary vascular resistance. 199 The contributions of increased vascular amiloride-sensitive Na + channel activity to increased medullary blood flow, and reduced ENaC activity to increased Na + excretion could explain the pressurenatriuresis phenomenon. The absolute increases in excretion that maintain Na + balance in response to volume-mediated increases in systemic blood pressure Aldosterone binds the MR in cytosol, which leads to the translocation of the complex into the nucleus. In endothelial cells, MR induces the transcription of two calcium-activated potassium channels (SK Ca and IK Ca ). 201 These channels are responsible for an outward current of potassium and, therefore, a hyperpolarization of the endothelial cells. When transduced to vascular smooth muscle cells (by gap junctions), hyperpolarization triggers relaxation. 202 MR also increases the number of EnNaCs at the apical membrane of endothelial cells, where Na + entry (and shear stress) can mediate cortical cell stiffness and eNOS phosphorylation. 141, 154 In vascular smooth muscle cells, MR increases the transcription of calcium channel Cav1.2, which increases intracellular calcium concentration, 170 and decreases expression of the BK Ca calcium-activated potassium channel. 203 In vascular smooth muscle cells, ENaC is part of the transduction pathway of constriction response to pressure (myogenic tone).
14,170 Whether ENaC is regulated by aldosterone in vascular smooth muscle cells has not yet been defined. Abbreviations: BK Ca , potassium big conductance calcium-activated channel; Cav1.2, calcium channel, voltage-dependent, L type; ENaC, epithelial sodium channel; EnNaC, endothelial cell amiloride-sensitive Na + channel; eNOS, endothelial nitric oxide synthase; IK Ca , potassium intermediate conductance calcium-activated channel; [K + ], potassium concentration; MR, mineralocorticoid receptor; NO, nitric oxide; RyR, ryanodine receptor; SK Ca , potassium small conductance calcium-activated channel.
are greater than can be explained by decreases in Na + reabsorption in the distal nephron, and imply that more proximal effects on Na + reabsorption could be explained by the redistribution of Na + transporters out of the apical membranes of the proximal tubule, 200 as well as increases in interstitial hydrostatic pressure. 199 
Conclusions
The balance between renal perfusion pressure, glomerular filtration and net renal Na + reabsorption achieves maintenance of volume homeostasis. Amiloridesensitive Na + channels and mineralocorticoid receptors are expressed in the aldosterone-sensitive distal nephron, vascular endothelial cells and vascular smooth muscle cells. In the presence of aldosterone and normal Na + concentrations in the arterial circulation, peripheral vascular resistance is maintained by the combination of endothelial cell stiffness and myogenic tone. A number of systems contribute to this maintenance, including hormones, and the sympathetic nervous system, as well as the intrinsic properties of the vascular cells themselves. Increased perfusion pressure, increased glomerular filtration, increased interstitial pressure and decreased proximal reabsorption deliver more Na + to the aldosterone-sensitive distal nephron. Inhibition of distal Na + reabsorption in conjunction with increased delivery of Na + to these sites closes the loop on what is referred to as 'pressure natriuresis' . Structural similarities exist between the amiloride-sensitive Na + channels in the epithelial, endothelial and smooth muscle cells, although endothelial cell Na + channels have not been sufficiently characterized at the molecular and structural level to conclude that prototypical ENaC complexes are expressed in endothelia. It is clear that αβγ ENaC complexes are not expressed in smooth muscle cells, however. Distinctions based on their functional differences, especially in response to changes in extra cellular Na + concentrations, might permit pharmacological approaches that could distinguish between the epithelial and other amiloride-sensitive Na + channels. Agents that preferentially inhibit the vascular channels could lower systemic blood pressure without the attendant inhibition of parallel K + secretion that accompanies the currently available Na + channel blockers and mineralocorticoid receptor antagonists.
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